The effect of saffron on binge eating disorder

Evaluating the effect of Crocus sativus L. (Saffron) on appetite and weight of subjects with binge eating disorder: A randomized, double-blind, placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20090117001556N149

Enrollment

Registered

2023-04-04

Start date

2023-05-22

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The severity of binge eating disorder. Anorexia nervosa, binge eating/purging type

Interventions

Intervention 1: Control group: patients take placebo capsules twice a day for three months. Intervention 2: Intervention group: patients take saffron capsules with a dose of 15 mg twice a day for thre

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Individuals with binge eating disorder confirmed by the SCID-V semi-structured questionnaire No specific diet Normal physical activity No drug or non-drug treatment

Exclusion criteria

Exclusion criteria: Diabetes Cancer Drug addiction Thyroid dysfunction Drugs effective in appetite and weight Taking psychiatric drugs Stomach surgery or taking food supplements Diagnosis of other eating disorders

Design outcomes

Primary

Measure	Time frame
The severity of binge eating disorder. Timepoint: Baseline, and weeks 4, 8, 12. Method of measurement: By SCID-V semi-structured questionnaire - DASS-21 questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shahin Akhondzadeh

Tehran University of Medical Sciences

s.akhond@sina.tums.ac.ir+98 21 5541 2222

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026